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More than thirty years after the discovery of HIV, the
HIV/AIDS epidemic continues to expand worldwide.
Undiagnosed HIV infections and late diagnoses remain
major public health challenges in all HIV-affected coun-
tries. According to recent estimates, the proportion of
persons living with HIV unaware of their infection
varies from >50% in sub-Saharan Africa to 20-50% in
European countries and 20-30% in North America. In
high-income countries, around 50% of new HIV diag-
noses are made late (i.e., when CD4 count is <350 cells
per μL); mean CD4 cell count at first presentation to
medical care in high-income countries was slightly
above 300 cells per μL in 2011, and has not increased
significantly over the past 20 years. In low- and middle-
income countries, most patients start HIV treatment
with CD4 counts well below the recommended thresh-
olds; the main reason for late initiation of HIV treat-
ment is late diagnosis.
Undiagnosed HIV infections and late diagnoses have
serious implications for both the individual and public
health. Patients diagnosed late cannot benefit fully from
timely initiation of HIV treatment and are more likely to
experience HIV-related morbidity and premature mortal-
ity. Undiagnosed HIV-infected individuals have a higher
risk of transmitting HIV than individuals aware of their
HIV infection, because they are not engaged in HIV treat-
ment (which greatly reduces the risk of transmission) and
cannot make informed decisions about their sexual beha-
vior. As a consequence, the majority of new HIV transmis-
sions may originate from individuals who are unaware of
their HIV infection.
Improving prevention and early diagnosis are thus key
objectives to reduce mortality and turning the tide on HIV
transmission. In this presentation, we will describe the
non-biomedical HIV prevention methods, including early
diagnosis, review and summarize the evidence supporting
(or not) their effectiveness and discuss how these methods
could be improved.
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